|
|
Volumn 55, Issue 8, 2007, Pages 430-438
|
|
Evaluation of C-reactive protein in primary and secondary prevention
a
|
|
Author keywords
Atherosclerosis; C reactive protein; Primary prevention; Screening
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTILIPEMIC AGENT;
ATORVASTATIN;
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
FIBRINOGEN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PLACEBO;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
TIROFIBAN;
ACUTE CORONARY SYNDROME;
ATHEROSCLEROSIS;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG STRUCTURE;
HEALTH PROGRAM;
HUMAN;
INFLAMMATION;
MEDICAL EDUCATION;
MEDICAL INFORMATION;
METABOLIC SYNDROME X;
PRACTICE GUIDELINE;
PRESCRIPTION;
PROPHYLAXIS;
PROTEIN ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SCORING SYSTEM;
TREATMENT DURATION;
|
|
EID: 39749191882
PISSN: 17088267
EISSN: None
Source Type: Journal
DOI: 10.2310/6650.2007.00023 Document Type: Review |
|
Times cited : (7)
|
|
References (31)
|
